Home » Stocks » CYRX

CryoPort, Inc. (CYRX)

Stock Price: $69.10 USD 1.79 (2.66%)
Updated Jan 27, 2021 4:00 PM EST - Market closed
After-hours: $68.20 -0.90 (-1.30%) Jan 27, 7:31 PM
Market Cap 3.15B
Revenue (ttm) 39.58M
Net Income (ttm) -22.11M
Shares Out 39.14M
EPS (ttm) -0.59
PE Ratio n/a
Forward PE 263.16
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $69.10
Previous Close $67.31
Change ($) 1.79
Change (%) 2.66%
Day's Open 66.01
Day's Range 63.80 - 72.81
Day's Volume 917,843
52-Week Range 13.56 - 82.11

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 2 days ago

NASHVILLE, Tenn., Jan. 25, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life scien...

PRNewsWire - 1 week ago

NASHVILLE, Tenn., Jan. 20, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life scien...

PRNewsWire - 1 week ago

NASHVILLE, Tenn., Jan. 19, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life scien...

The Motley Fool - 1 month ago

Both stocks are in the early stage of a long-term growth trajectory.

Other stocks mentioned: BCRX
CNBC Television - 1 month ago

Where investors are putting money to work in the Covid vaccine supply chain

CNBC's "Halftime Report" team is joined by Kate Kelly of The New York Times to discuss where investors are putting money along the vaccine supply chain, including cold storage.

Seeking Alpha - 1 month ago

With the approval of Yescarta and Kymriah in recent years, you are now seeing unprecedented growth in the CAR-T industry. Logistic providers that support CAR-T and gene therapies are profiting...

Bloomberg Markets and Finance - 1 month ago

Logistics of Vaccine Distribution Challenging: Cryoport CEO

Dec.01 -- Cryoport Inc. looks forward to the opportunity to participate in the distribution of the Covid-19 vaccines and admits the logistics will be challenging, Chief Executive Officer Jerre...

Seeking Alpha - 2 months ago

Cryoport is a strong cold chain platform focused on the fast-growing cell and gene therapy end-market. Company has demonstrated strong execution through COVID and, with recent acquisitions, wi...

Seeking Alpha - 2 months ago

Cryoport's operating model remains insulated via key differentiators in the thermoregulatory logistics domain, with cloud-based integration along the audit chain. Linking with larger players i...

Forbes - 2 months ago

Excited about the Covid-19 vaccines from Pfizer and Moderna? You'll be waiting a long time unless the vaccines can be shipped at 94 degrees below zero.

Other stocks mentioned: AVTR, MCK, TMO, UPS
Seeking Alpha - 2 months ago

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

NASHVILLE, Oct. 29, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in life sciences solutions, today announced that the Company will report f...

PRNewsWire - 3 months ago

NASHVILLE, Tenn., Oct. 1, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), the life sciences industry's preeminent partner for temperature-controlled supply ch...

CNBC Television - 4 months ago

Final Trades: CrowdStrike, Cryoport, Industrials & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: CRWD, LAMR, XLI
CNBC Television - 4 months ago

How Cryoport plays a role in the coronavirus fight

CNBC's "Power Lunch" team talks about Cryoport's stock rally with Cryoport CEO Jerrell Shelton.

The Motley Fool - 5 months ago

Cryoport is acquiring Chart's cryobiological business and getting a big boost from one of the giants in private equity.

Zacks Investment Research - 5 months ago

Cryoport (CYRX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

PRNewsWire - 5 months ago

NASHVILLE, Tenn., Aug. 25, 2020 /PRNewswire/ -- Cryoport, Inc.

PRNewsWire - 5 months ago

NASHVILLE, Tenn., Aug. 21, 2020 /PRNewswire/ -- Cryoport, Inc.

Seeking Alpha - 5 months ago

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

NASHVILLE, Tenn., Aug. 6, 2020 /PRNewswire/ -- Cryoport, Inc.

PRNewsWire - 5 months ago

NASHVILLE, Tenn. and TOKYO, Aug.

PRNewsWire - 5 months ago

NASHVILLE, Tenn., Aug. 3, 2020 /PRNewswire/ -- Cryoport, Inc.

PRNewsWire - 8 months ago

NASHVILLE, Tenn., May 21, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport") today announced the pricing on May 20, 2020 of its offering of $100.0 million in aggregate principal a...

PRNewsWire - 8 months ago

NASHVILLE, Tenn., May 19, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport") today announced its intention to offer, subject to market and other conditions, $100.0 million in aggr...

Seeking Alpha - 8 months ago

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

CryoPort: Profiting From CAR-T

The Motley Fool - 1 year ago

Buckle up, shareholders, and prepare for a miss in Q4.

Seeking Alpha - 1 year ago

Cryoport: Cold Chain Is A Hot Business Model

Seeking Alpha - 1 year ago

Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Cryoport's (CYRX) CEO Jerry Shelton on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Both companies operate in the same market and are of similar size and produce comparable growth rates, yet CryoPort sells at 2.5x the valuation of BioLife.

Other stocks mentioned: BLFS
Seeking Alpha - 1 year ago

Chimeric Antigen Receptor/T-Cell Receptor (CAR-T) is powering a fundamental shift for treating deadly cancers.

Seeking Alpha - 1 year ago

Cryoport's (CYRX) CEO Jerry Shelton on Q1 2019 Results - Earnings Call Transcript

The Motley Fool - 1 year ago

CYRX earnings call for the period ending December 31, 2018.

About CYRX

Cryoport provides temperature-controlled logistics and biostorage services to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resol... [Read more...]

Industry
Integrated Freight & Logistics
Founded
1999
CEO
Jerrell W. Shelton
Employees
105
Stock Exchange
NASDAQ
Ticker Symbol
CYRX
Full Company Profile

Financial Performance

In 2019, CryoPort's revenue was $33.94 million, an increase of 72.94% compared to the previous year's $19.63 million. Losses were -$18.33 million, 91.8% more than in 2018.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for CryoPort stock is "Strong Buy." The 12-month stock price forecast is 63.29, which is a decrease of -8.41% from the latest price.

Price Target
$63.29
(-8.41% downside)
Analyst Consensus: Strong Buy